Immunocore Holdings PLC (IMCR) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Net Revenue: $400 million from KimTrack, up 29% from the prior year. Cash and Marketable Securities: Approximately $864 million, an increase of over $40 million from the previous year. KimTrack Approval and Launch: Approved in 39 countries and launched in 30 markets. Market Penetration: Over 70% penetration across all major markets for KimTrack. Mean Duration of Therapy: 14 months for KimTrack. Operating Expenses: Increased due to investments in three phase 3 trials and early-stage programs. SG&A Expenses: Marginally higher than 2024, with expected incremental increases in 2026. Operating Loss: Reduced in 2025 as revenue growth outpaced operating expenses. Warning! GuruFocus has detected 4 Warning Signs with IMCR. Is IMCR fairly valued? Test your thesis with our free DCF calculator. Release Date: February 25, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Posit
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- Immunocore to present at upcoming investor conferencesGlobeNewswire
- Is It Time To Revisit Immunocore Holdings (IMCR) After Recent Pipeline Progress? [Yahoo! Finance]Yahoo! Finance
- Immunocore (IMCR) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
- Immunocore (IMCR) had its price target raised by Needham & Company LLC from $71.00 to $75.00. They now have a "buy" rating on the stock.MarketBeat
- Immunocore Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
IMCR
Earnings
- 2/25/26 - Miss
IMCR
Sec Filings
- 2/25/26 - Form 8-K
- 2/25/26 - Form 10-K
- 2/19/26 - Form 4
- IMCR's page on the SEC website